Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04950504
Status:
TERMINATED
Last Update Posted:
2023-09-18
First Post:
2021-06-03
Brief Title:
Evaluate the Safety Tolerability Pharmacodynamics and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Sponsor:
COUR Pharmaceutical Development Company Inc
Organization:
COUR Pharmaceutical Development Company Inc
Organization Data
Organization:
COUR Pharmaceutical Development Company Inc
Class:
INDUSTRY
Study ID:
CNP-201-5001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
COUR Pharmaceutical Development Company Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None